SearchNCIt concept

https://publications.msss.gouv.qc.ca/msss/document-001048/
2024
false
false
false
Canada
patient education handout
Other Establishment Activity
Province
research
Other Cytogenetic Analysis Abnormality Type
Other Edition
Other License Status
Performance Status Scale Timing Other
Other Molecular Analysis
adoption
Other Medication Given for Kawasaki Disease
Other Health Care Professional
Other Frequency of Chief Complaint
Research
Other Blood Form Product
homing behavior
Other Medication Given for Rheumatic Fever
Specify Another Form of Birth Control that was Used
History of Other Medical Treatment
Other HPV Typing Method
Other Race
History of Other Non-Cardiac Surgery
Other Tumor Site
Other Gender
Adopted Son
Other Pathologic Findings
HPV-Other Type
Other Histologic Type
Unknown if Has Sibling
Other Route of Administration
Other Eye Color
Other Non-Neoplastic Finding
Other Histologic Grade
Search
adoption, nos
Other Presenting Finding of Congenital Heart Disease
Other Anatomic Site
Other Exacerbating Factor to Chief Complaint
CDISC Define-XML Origin Source Terminology

---
https://publications.msss.gouv.qc.ca/msss/document-003771/
2024
Canada
technical report
Research
adoption, nos
research
CDISC Define-XML Origin Source Terminology
adoption
Search
statistics
Adopted Son
Sample Statistic
Statistics
statistics as topic

---
https://www.srlf.org/article/lintelligence-artificielle-au-service-recherche-reanimationthink-different
2024
false
false
false
France
critical appraisal or critical reading
Search
Research
Difference
Artificial Intelligence
Software Service
Department
research
intelligence, nos
artificial intelligence

---
https://recherche.chu-rouen.fr/
2024
France
research structure
research
hospitals, university
Research
Search

---
https://www.anses.fr/fr/system/files/RSC-Co-1306-Cecile-MICHEL.pdf
2024
France
scientific and technical information
Disturbance
Disruption
endocrine gland, nos
endocrine disruptors
New Lesion Identification
Despondency
Search
research
Research
Newar Language

---
https://www.canal-u.tv/chaines/progedo/des-donnees-sur-le-vieillissement-besoins-et-contraintes-des-differents-champs-d
2024
France
audiovisual aids
health services needs and demand
Need
aging
action research
needs
Constrain
Restriction
Quantitative Constraint
Password Aging
Aging
Data Field
Regulatory Action
Research
stress, physiological
dataset
Search
aging

---
https://drees.solidarites-sante.gouv.fr/article/la-mission-recherche-mire
2024
France
scientific and technical information
research
Research
Search
Religious Missions

---
https://publications.msss.gouv.qc.ca/msss/document-003710/
2024
Canada
handbooks
Change
family
legislation
Alteration
Search
Data Change Date
legislation as topic
family research
Research
Household
GDC Procedures Performed Terminology
Tumor Laterality Right
sociobiology
case histories
family, nos
Modified-release Mechanism of Action
Family Study
Copyright
Modified
Amendment
Modification
Amended

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/equivalence-du-seuil-de-positivite-des-tests-immunochimiques-de-recherche-de-sang-occulte-dans-les-selles-pour-le-depistage-du-cancer-colorectal.html
2024
Canada
review of literature
feces
early detection of cancer
Equivalent
screening for occult blood in feces
cancer screening
screening for cancer
Research
Search
research
immunochemistry
Blood in Stool
colorectal neoplasms
Occult Blood Measurement
Colorectal Cancer
Screening for Colorectal Cancer
occult blood
Liquid Tumor
malignant neoplasm colon/rectum

---
https://publications.msss.gouv.qc.ca/msss/document-003730/
2024
Canada
popular works
research
People
residence characteristics
domicile
CDISC Define-XML Origin Source Terminology
persons
Adopted Son
quebec
adopted person, nos
intention
Stay at Home Parent
Research
adoption
Search
parents
adoptive parent

---
https://www.anses.fr/fr/content/CDLR-mg-pe-23
https://www.anses.fr/fr/system/files/CDLR-mg-pe-23.pdf
2024
France
popular works
Disturbance
N Category
Signal to Noise Ratio
Despondency
endocrine disruptors
Phase II/III Trial
Twenty Three
Disruption
endocrine gland, nos
Research
Nano
Search
research
Tumor to Normal
MATCH Arm EAY131-N
No
N
Newton

---
https://dumas.ccsd.cnrs.fr/dumas-04248048v1
2023
France
dissertations, academic
Regulatory Action
First Degree Family History Cancer Negative
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Has No Sibling
10q23/PTEN Locus Deletion Analysis Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
Use of Smokeless Tobacco at Time of Diagnosis Negative
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Regional Anesthesia was not Administered
Other Preoperative IV Medications were not Administered
PTEN Mutation Analysis Was Not Performed
Norway
Minor Criteria for Rheumatic Heart Disease Not Present
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
No History of Rheumatic Fever
Negation
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Radiation Therapy Not Received
Chief Complaint Not Caused by Trauma
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
TP53 Mutation Analysis Was Not Performed
No Known History of Alcohol Use
1p/19q Deletion Analysis Was Not Performed
Additional Molecular Studies Were Not Performed
RET Rearrangement Analysis Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
Research
Failure
Any Metastatic Diagnosis Absent
Additional Immunohistochemistry Was Not Performed
Intervention Not Given for Kawasaki Disease
Patient was not Postmenopausal with no Prior Oophorectomy
ATRX Gene Mutation Negative
Preoperative IV Opiates were not Administered
Hypertension Absent
ERBB2 Mutation Analysis Was Not Performed
Medication Not Taken
History of Colorectal Cancer Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
Adjuvant I-131 Therapy Negative
Adjuvant Post-operative Immunological Therapy Was Not Administered
Neither
Evidence of Disease Absent after Completion of Therapy
Nitric Oxide Measurement
Tumor Progression Absent After Initial Treatment
No History of Neonatal Complication
Additional Surgery for New Tumor Event Absent
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
NF1 Mutation Analysis Was Not Performed
Neither Case or Control Status
Physician Diagnosed Diabetes Absent
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Additional Surgery for New Metastatic Tumor Event Was Not Performed
IV Anesthesia was not Administered
Chemical/Occupational Exposure Absent
Preoperative IV Antiemetics were not Administered
Participation
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
IDH Family Wildtype
BRAF Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Preoperative IV Antacids were not Administered
Caffeine Not Routinely Consumed
ATRX Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
First Degree Family History Thyroid Cancer Negative
Regular Smokeless Tobacco Use for Six Weeks or More Negative
PDGFRA Mutation Analysis Was Not Performed
Not Lost to Follow-Up
Search
Tumor Reoccurrence Absent After Initial Treatment
No Known History of Illicit Drug Use
Nitric Oxide
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
NON Mouse
Preoperative IV Sedation was Not Administered
Radiation History Negative
No History of Non-Cardiac Surgery
NRAS Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
No History of Congenital Heart Disease
IDH Family Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Chemotherapy Not Received
History of Medical Treatment Absent
Patient was Not Previously Evaluated for Current Chief Complaint
Unemployed
play and playthings
MGMT Promoter Methylation Testing Was Not Performed
Documentation Absent
Lymph Node Dissection Was Not Performed
No History of Gestational Complication
No History of Myopathy
health services research
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
PTEN Gene Mutation Negative
Cancer History Absent
Paraneoplastic Syndrome is Not Present
EGFR Mutation Analysis Was Not Performed
action research
No Response to Intervention for Kawasaki Disease
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Family History of Stomach Cancer Absent
New Tumor Event After Initial Treatment Absent
No History of Kawasaki Disease
Chief Complaint was Not Witnessed
Another Form of Birth Control was not Used
EGFR Amplification Analysis Was Not Performed
Local Anesthesia Agents were not Administered
Intercurrent Illness is Absent at Onset of Chief Complaint
New Disease is not Multifocal
Adjuvant Post-operative Chemotherapy Was Not Administered
MET Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
ALK Rearrangement Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
play
First Degree Family History of Primary Brain Tumor Negative
EGFR Gene Amplification Negative
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
BRAF Rearrangement Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panel-pour-la-recherche-de-mutations-myeloides-par-sequencage-de-nouvelle-generation.html
2023
Canada
technical report
generations
Search
Next Generation Sequencing
Novel Mutation
mutation
Research
family characteristics
sequence analysis
research
Myeloid Mutation Panel
sequence determinations

---
https://www.academie-medecine.fr/seance-du-19-septembre-levaluation-de-la-recherche-en-biologie-et-en-sante/
2023
France
congresses
video recording
biology
Research
Nineteen
evaluation studies as topic
Medical Examination
Biotechnology
Biological Agent
Search
biology
Session
biomedical research
September
evaluation research
health

---
https://www.irdes.fr/recherche/podcasts.html#01
2023
France
sound
Tumor Regression Score 1
1+ Score, WHO
1+ Score
Symptoms Extent Score 1
CDISC SDTM Model Version 1.6
One
One Hundred Percent
EDQM-HC Administration Method Terminology
Agreement Score 1
Search
research
Intensity and Distress 1
N
No
ECOG Performance Status 1
Gleason Grade Group 1
Mild Adverse Event
MATCH Arm EAY131-N
Phase I Trial
Signal to Noise Ratio
Research
CDISC SDTM Model Version 1.5
Nano
N Category
Severity of Symptom Score 1
Clinical Status Ordinal Scale Outcome 1
Newton
Illness Intrusiveness Rating 1
Neck Pain Score 1
Questioning
Never Smoker
news
One Full Term Pregnancy
Thought Score 1
Upset Score 1
Tumor to Normal
Fear Score 1

---
https://iris.who.int/handle/10665/369131
2023
Switzerland
technical report
biology
Biological Son
risk
Lifetime Risk
attenuated by
Referral
Biology
CDISC SDTM Environmental Setting Terminology
hazardous substances
CDISC ADAS-Cog - Orientation Summary Score
Biological Challenge Agent
biological science disciplines
Biotechnology
Biological
Usage
Research
orientation
Referring
research
orientation, nos
Direction
Montreal Cognitive Assessment Orientation Test
biology
Biological Agent
science
Responsible Person
life
Mitigate
Biological or Textual Reference to Actual Test or Parameter
Orientation
Search

---